Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832375 · ClinicalTrials.gov registry record · Phase 3
Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 242
- Enrollment target
NCT02832375 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 242 participants.
The verdict
NCT02832375, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 242 participants
- Enrollment target
Study Summary
This single center, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.
Interventions
- DRUG stannous fluoride
- DRUG sodium monofluorophosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2016-05-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832375
The ClinicalTrials.gov registry entry for NCT02832375 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which stannous fluoride is the first listed.
NCT02832375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02832375 about?
NCT02832375 is a clinical study titled "Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity". This single center, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.
What is the current status of trial NCT02832375?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 242 participants. The study started on 2016-03-01. Estimated completion is 2016-05-12.
What interventions are being tested in trial NCT02832375?
The interventions under investigation include: stannous fluoride (DRUG), sodium monofluorophosphate (DRUG).
Who is sponsoring clinical trial NCT02832375?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.